Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000339325

Medchemexpress LLC SPR719 (VXc-486) | 1384984-18-2 | 99.4% | 100 MG
SDP

Catalog No. 5000339325
Encompass_Preferred

SPR719 (VXc-486) is an orally active gyrase B inhibitor with bactericidal activity. It shows promise for research into lung disease caused by non-tuberculous mycobacteria (NTM). It potently inhibits multiple agent-sensitive and drug-resistant isolates of *Mycobacterium tuberculosis*.

  • Potently inhibits *Mycobacterium tuberculosis*
  • Active against agent-sensitive and drug-resistant isolates
  • Promising for research into lung disease caused by non-tuberculous mycobacteria
  • Inhibits *M. tuberculosis* replication in macrophages

Catalog No. 50-003-39325 Supplier Medchemexpress LLC Supplier No. HY12930100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

SPR719 (VXc-486) is an orally active gyrase B inhibitor with bactericidal activity. It shows promise for research into lung disease caused by non-tuberculous mycobacteria (NTM). It potently inhibits multiple agent-sensitive and drug-resistant isolates of *Mycobacterium tuberculosis*.

  • Potently inhibits *Mycobacterium tuberculosis*
  • Active against agent-sensitive and drug-resistant isolates
  • Promising for research into lung disease caused by non-tuberculous mycobacteria
  • Inhibits *M. tuberculosis* replication in macrophages

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.